Safety Rates Drug Report: FUROSEMIDE. Maternal exposure during pregnancy adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

The Safety Rates Drug Report

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: FUROSEMIDE. Injury: Maternal exposure during pregnancy Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 10 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
123202242	FUROSEMIDE.	Maternal exposure during pregnancy	MYLAN	0.00		0	20160720	IT
123202352	FUROSEMIDE.	Maternal exposure during pregnancy	MYLAN	0.00		0	20160720	IT
123202572	FUROSEMIDE.	Maternal exposure during pregnancy	MYLAN	0.00		0	20160720	IT
124937473	FUROSEMIDE.	Maternal exposure during pregnancy	PFIZER	0.00	F	0	20160706	IT
124979752	FUROSEMIDE.	Maternal exposure during pregnancy	TEVA	32.00 YR	F	0	20160707	IT
125223222	FUROSEMIDE.	Maternal exposure during pregnancy	VALIDUS	32.00 YR	F	0	20160802	IT
125248992	FUROSEMIDE.	Maternal exposure during pregnancy	TAKEDA	32.00 YR	F	0	20160708	IT
125284433	FUROSEMIDE.	Maternal exposure during pregnancy	VALIDUS	27.00 YR	F	0	20160824	TR
126156132	FUROSEMIDE.	Maternal exposure during pregnancy	CONCORDIA	28.00 YR	F	0	20160811	US
127606602	FUROSEMIDE.	Maternal exposure during pregnancy	SANDOZ	21.00 YR	F	0	20160920	US

|< 1/2 << Previous Page Page 1

Total Records: 10 Number of Pages: 1

Execution Time: 0.03308892250061 seconds (ucode:5229374). Developed by: James D. Barger